Combined Cognitive and Vocational Interventions After Mild-to-moderate TBI: a Randomized Controlled Trial

October 11, 2021 updated by: Nada Andelic, Oslo University Hospital

The Effect Evaluation of Combined Cognitive and Vocational Interventions After Mild-to-moderate Traumatic Brain Injury: a Randomized Controlled Trial and Qualitative Process Evaluation

A considerable number of patients with mild and moderate traumatic brain injury (TBI) experience long-lasting somatic, cognitive, and emotional symptoms that may hamper their capacity to return to work (RTW). Although several studies have described medical, psychological and work-related factors that predict RTW after TBI, well-controlled intervention studies regarding RTW in this group are scarce. Furthermore, there have traditionally been weak collaborations among rehabilitation services in the health sector, the Labor and Welfare Administration (NAV), and the work-places.

The current project proposal describes an innovative randomized controlled trial (RCT) which will explore the effect of combined manualized cognitive rehabilitation efforts and supported employment in real-life competitive work settings for patients who have not returned to work 8 weeks post-injury. The project combines the rehabilitation and vocational science perspectives; it involves multidisciplinary collaboration, and explores the efficacy of increased cross-sectorial collaboration between specialized health care services and the welfare system. If the intervention proves efficient, the project will further describe the cost-effectiveness and utility of the program, and thereby provide important information of use for policy makers. In addition, the study aims at generating knowledge on the RTW-process both for the persons with TBI, and their workplaces, and to disseminate this knowledge in order to create new multidisciplinary and collaborative practices. The project has potential to generate knowledge of relevance for other patients with neurological deficit.

Study Overview

Detailed Description

Please, see protocol article: https://www.ncbi.nlm.nih.gov/pubmed/29041954

Study Type

Interventional

Enrollment (Actual)

121

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0424
        • Oslo University Hospital, Dept. of physical medicine and rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • reside in Oslo and Akershus counties in Norway
  • mild-to-moderate TBI (Glasgow Coma scale score 10-15 at injury site). Confirmation of diagnosis of mild TBI will be done through documenting that acute symptoms adhere to the American Congress of Rehabilitation Medicine's (ACRM) definition of mild TBI.
  • loss of consciousness <24 hours
  • posttraumatic amnesia (PTA) <7 days
  • employed in a minimum 50% position at the time of injury
  • sick listed at the 50% or higher level due to post-concussive symptoms 2 months post-injury

Exclusion Criteria:

  • history of severe psychiatric or neurological illness
  • active substance abuse
  • inability to speak and read Norwegian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Cognitive Intervention and Supported Employment (CCI-SE)
Combined cognitive and vocational rehabilitation in a mixed design.
The CCI-SE Group receives a manualized Group-based cognitive psycho-educational intervention (10 sessions), combined with supported employment at their work-place.
ACTIVE_COMPARATOR: Control group
Usual follow-up assessment and treatment provided by the multidisciplinary TBI rehabilitation team.
The Control Group receives usual assessment and treatment at Oslo University Hospital.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return to work
Time Frame: 18 months post injury
The effect of the intervention on return to work rates throughout the follow-up period
18 months post injury
Work stability
Time Frame: 18 months post injury
The effect of the intervention on work stability rates throughout the follow-up period
18 months post injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rivermead post-concussion questionnaire
Time Frame: 18 months
Questionnaire; The effect of the study intervention on post concussive symptoms
18 months
Euro-Qol - 5D (EQ-5D)
Time Frame: 18 months
Questionnaire; The effect of the study intervention on health-related quality-of-life throughout the follow-up period
18 months
Quality of life after brain injury (Qolibri)
Time Frame: 18 months
Questionnaire; The effect of the study intervention on disease-related quality-of-life throughout the follow-up period
18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue Severity Scale
Time Frame: 18 months
Questionnaire; The effect of the study intervention on fatigue throughout the follow-up period
18 months
Insomnia Severity Index
Time Frame: 18 months
Questionnaire; The effect of the study intervention on sleep throughout the follow-up period
18 months
Cognitive Failures Questionnaire
Time Frame: 18 months
Questionnaire; The effect of the study intervention on self-reported cogntiive symptoms throughout the follow-up period
18 months
Generalized Anxiety Disorder (GAD-7)
Time Frame: 18 months
Questionnaire; The effect of the study intervention on anxiety throughout the follow-up period
18 months
Patient Health Questionnaire (PHQ-9)
Time Frame: 18 months
Questionnaire; The effect of the study intervention on depression throughout the follow-up period
18 months
General Self-efficacy Scale
Time Frame: 18 months
Questionnaire; The effect of the study intervention on self-efficacy throughout the follow-up period
18 months
Neuropsychological functioning
Time Frame: 18 months
Screening test battery including measures of general ability Level, attention, Processing speed, Learning and memory executive functioning, and performance validity
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nada Andelic, MD; PhD, Oslo University Hospital/University of Oslo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 2, 2017

Primary Completion (ACTUAL)

December 31, 2020

Study Completion (ACTUAL)

June 30, 2021

Study Registration Dates

First Submitted

March 10, 2017

First Submitted That Met QC Criteria

March 21, 2017

First Posted (ACTUAL)

March 28, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 19, 2021

Last Update Submitted That Met QC Criteria

October 11, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Combined cognitive (Compensatory Cognitive Training - CCT) and vocational rehabilitation (Supported Employment)

Subscribe